Intravenous (IV) Solutions Market - North America, Europe, EMEA, APAC : US, Canada, China, Germany, UK - Forecast 2023-2027

Published: Apr 2023 Pages: 153 SKU: IRTNTR75229

Intravenous (IV) Solutions Market Analysis Report: 2023-2027

The intravenous (IV) solutions market size is estimated to grow at a CAGR of 7.11% between 2022 and 2027. The market size is forecast to increase by USD 4,011.34 million. The growth of the intravenous solutions market depends on several factors, including the increasing prevalence of chronic diseases, the growing geriatric population, and the increasing demand for parenteral nutrition.

This intravenous solutions market report extensively covers market segmentation by type (partial parenteral nutrition and total parenteral nutrition), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and geography (Asia, North America, Europe, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. 

What will be the Size of the Intravenous Solutions Market During the Forecast Period?

To learn more about this report, Request Free Sample

Intravenous IV Solutions Market: Key Drivers, Trends, Challenges, and Customer Landscape

 Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Intravenous IV Solutions Market Drivers

The increasing prevalence of chronic diseases is notably driving the Intravenous (IV) Solutions Market growth. The market is growing rapidly due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. IV solutions are used to treat a variety of medical conditions and are critical for delivering fluids, electrolytes, and medications to patients. According to the International Diabetes Federation (IDF), the number of people with diabetes is expected to reach 700 million by 2045. Diabetic patients require intravenous solutions for glucose control, and the increasing prevalence of diabetes is expected to increase the demand for intravenous solutions during the forecast period.

In addition, the increasing number of cancer cases is also boosting the growth of the market. Cancer patients often require intravenous solutions to manage chemotherapy side effects such as dehydration and electrolyte imbalance. According to the American Cancer Society, the number of cancer cases worldwide is expected to reach 28.4 million by 2040, which should further increase the demand for IV solutions. Hence, the increasing prevalence of chronic diseases is expected to boost the growth of the market during the forecast period.  

Significant Intravenous IV Solutions Market Trends

Technological advancements in IV solutions are a key trend influencing the IV Solutions Market growth. IV solutions are used to deliver medicines, fluids, and nutrients directly into the bloodstream and are an important part of modern medical practice. The latest technological advancements in IV solutions have improved their efficiency, safety, and effectiveness, thereby driving the market. One of the recent technological advances in the IV solutions market is the development of intelligent IV pumps. Intelligent IV pumps are designed to improve patient safety and reduce the risk of medication errors by automatically adjusting infusion rates based on patient weight, age, and medical condition. 

Another technological advancement in the market is the development of closed system transfer devices (CSTDs). CSTDs are designed to protect healthcare workers from exposure to dangerous drugs during the preparation and administration of intravenous therapy. CSTDs are becoming increasingly important in cancer therapy, where dangerous drugs are frequently used. Moreover, the use of nanotechnology in IV solutions is another technological breakthrough driving the market globally. Nanotechnology is being used to develop infusion solutions that deliver drugs and nutrients to the body more effectively and efficiently. Technological advances in IV solutions are expected to drive the growth of the market by improving the safety, efficacy, and efficiency of IV therapies. 

Major Intravenous IV Solutions Market Challenges

The high cost of IV solutions is challenging the Intravenous Solutions Market growth. The cost of IV solutions continues to increase and this trend is expected to continue during the forecast period. This cost increase is due to several factors, such as the high cost of raw materials, manufacturing processes, and transportation costs.  The high cost of IV solutions hinders the global market in several ways. First, demand for IV solutions is declining as many healthcare providers and patients cannot afford IV solutions due to their high cost. This is especially true in developing countries where access to affordable healthcare is already limited. Furthermore, the high cost of IV solutions has led to lower profitability for IV solution manufacturers and distributors. This is because many healthcare providers are switching to cheaper alternatives such as oral medications and subcutaneous injections to cut costs.

Many cancer patients require IV solutions as part of their treatment, but the high cost of these solutions can place a financial burden on both patients and healthcare providers. Therefore, the high cost of IV solutions is a major challenge for the intravenous Solutions Market during the forecast period.  

Key Intravenous IV Solutions Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Intravenous IV Solutions Market Customer Landscape

Who are the Major Intravenous IV Solutions Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the intravenous solutions market.

Amanta Healthcare Ltd: The company offers a wide range of IV solutions, including rehydration solutions such as sodium chloride, dextrose, and pre-mixed solutions such as sodium chloride injection, in pack sizes from 100mL to 500mL. 

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • Axa Parenterals Ltd.
  • Baxter International Inc.
  • Fresenius SE and Co. KGaA
  • Grifols SA
  • ICU Medical Inc.
  • JW Pharmaceutical Corp.
  • Lxir Medilabs Pvt. Ltd.
  • MITS Healthcare Pvt. Ltd.
  • Pfizer Inc.
  • Salius Pharma Pvt. Ltd.
  • Schwitz Biotech
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Soxa Formulations and Research Pvt. Ltd.
  • Terumo Group
  • Vifor Pharma Management Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Intravenous IV Solutions Market?

The market share growth by the partial parenteral nutrition segment will be significant during the forecast period. Partial parenteral nutrition (PPN) is a type of IV therapy that provides partial nutritional support to patients who cannot obtain adequate oral nutrition. It is used when the patient's gastrointestinal tract is partially functioning, but oral intake is not sufficient to meet the body's needs. PPN solutions typically contain combinations of glucose, electrolytes, and amino acids in varying ratios based on the patient's specific needs. For example, patients with liver disease may require solutions with low concentrations of amino acids, and patients with renal failure may require solutions with high concentrations of electrolytes. 

Get a glance at the market contribution of various segments View the PDF Sample

The partial parenteral nutrition segment was valued at USD 3,735.46 million in 2017 and continued to grow until 2021. Partial parenteral nutrition (PPN) is often used in combination with enteral nutrition (EN). With EN, nutrients are delivered directly to the gastrointestinal tract via a feeding tube. The use of both PPN and EN is called dual nutritional support and is common in critically ill patients. PPN is a type of IV solution used to provide partial nutritional support to patients who cannot obtain adequate nutrients orally. Hence, this segment will contribute to the growth of the market during the forecast period. 

Which are the Key Regions for the Intravenous IV Solutions Market?

For more insights on the market share of various regions Download PDF Sample now!

Asia is estimated to contribute 33% to the growth of the global intravenous IV solutions market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Asia is projected to be the largest market in 2022 and the forecast period, with Japan, China, Singapore, India, and South Korea being the largest contributors in terms of revenue. The market is driven by rising healthcare costs, the rising prevalence of chronic diseases, and an aging population. The growing focus of key market players on emerging markets, increasing disposable income, the introduction of infusion therapy devices, and the increasing number of clinics and hospitals such as Fortis Healthcare (India) and Singapore General Hospital (Singapore) are also contributing to market growth.

The COVID-19 outbreak had a significant impact on market growth in 2020. The pandemic increased the demand for IV solutions. This enabled intensive care unit (ICU) patients to receive essential medicines and nutrients. In addition, important growth-promoting factors are the increasing prevalence of diabetes, cancer, gastrointestinal disorders, and neurological diseases. In addition, the superior efficacy and shorter response time of IV solution therapy fueled the market expansion in 2020. Additionally, R&D activity also fueled market growth due to the easing of lockdown restrictions and the launch of the COVID-19 vaccine. Some business and industrial activities resumed with appropriate safety and precautionary measures in place, increasing the production of IV solutions. In addition, the increasing prevalence of chronic diseases such as cancer and the increasing geriatric population whose patients need to receive essential nutritional products via intravenous route will drive the growth of the market during the forecast period. 

Segment Overview

The intravenous IV solutions market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook (USD Million, 2017 - 2027)
    • Partial parenteral nutrition
    • Total parenteral nutrition
  • Distribution Channel Outlook (USD Million, 2017 - 2027)
    • Hospital pharmacy
    • Retail pharmacy
    • Online pharmacy
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Middle East
      • South Africa

Intravenous IV Solutions Market Scope

Report Coverage

Details

Page number

153

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.11%

Market growth 2023-2027

USD 4011.34 million

Market structure

Fragmented

YoY growth 2022-2023(%)

6.68

Regional analysis

Asia, North America, Europe, and Rest of World (ROW)

Performing market contribution

Asia at 33%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Amanta Healthcare Ltd., Axa Parenterals Ltd., Baxter International Inc., Fresenius SE and Co. KGaA, Grifols SA, ICU Medical Inc., JW Pharmaceutical Corp., Lxir Medilabs Pvt. Ltd., MITS Healthcare Pvt. Ltd., Pfizer Inc., Salius Pharma Pvt. Ltd., Schwitz Biotech, Sichuan Kelun Pharmaceutical Co. Ltd., Soxa Formulations and Research Pvt. Ltd., Terumo Group, Vifor Pharma Management Ltd., Vikrant Life Sciences Pvt. Ltd., Vitapure Corp., B. Braun Melsungen AG, and Otsuka Holdings Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View the PDF sample

What are the Key Data Covered in this Intravenous IV Solutions Market Research Report?

  • CAGR of the intravenous solutions market during the forecast period
  • Detailed information on factors that will drive the growth of intravenous IV solutions between 2023 and 2027
  • Precise estimation of the size of the intravenous IV solutions market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across Asia, North America, Europe, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of intravenous IV solutions market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global intravenous (IV) solutions market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global intravenous (iv) solutions market 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 Distribution Channel Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Partial parenteral nutrition - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Partial parenteral nutrition - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Partial parenteral nutrition - Year-over-year growth 2022-2027 (%)
    • 6.4 Total parenteral nutrition - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Total parenteral nutrition - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Total parenteral nutrition - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)
      • Exhibit 43: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by Distribution Channel

    • 7.1 Market segments
      • Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
    • 7.2 Comparison by Distribution Channel
      • Exhibit 46: Chart on Comparison by Distribution Channel
      • Exhibit 47: Data Table on Comparison by Distribution Channel
    • 7.3 Hospital pharmacy - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
    • 7.4 Retail pharmacy - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
    • 7.5 Online pharmacy - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Distribution Channel
      • Exhibit 60: Market opportunity by Distribution Channel ($ million)
      • Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 Asia - Market size and forecast 2022-2027
      • Exhibit 67: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 68: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 70: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.4 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.5 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.10 UK - Market size and forecast 2022-2027
      • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ million)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 Amanta Healthcare Ltd.
              • Exhibit 111: Amanta Healthcare Ltd. - Overview
              • Exhibit 112: Amanta Healthcare Ltd. - Product / Service
              • Exhibit 113: Amanta Healthcare Ltd. - Key offerings
            • 12.4 Axa Parenterals Ltd.
              • Exhibit 114: Axa Parenterals Ltd. - Overview
              • Exhibit 115: Axa Parenterals Ltd. - Product / Service
              • Exhibit 116: Axa Parenterals Ltd. - Key offerings
            • 12.5 B. Braun Melsungen AG
              • Exhibit 117: B. Braun Melsungen AG - Overview
              • Exhibit 118: B. Braun Melsungen AG - Business segments
              • Exhibit 119: B. Braun Melsungen AG - Key news
              • Exhibit 120: B. Braun Melsungen AG - Key offerings
              • Exhibit 121: B. Braun Melsungen AG - Segment focus
            • 12.6 Baxter International Inc.
              • Exhibit 122: Baxter International Inc. - Overview
              • Exhibit 123: Baxter International Inc. - Business segments
              • Exhibit 124: Baxter International Inc. - Key news
              • Exhibit 125: Baxter International Inc. - Key offerings
              • Exhibit 126: Baxter International Inc. - Segment focus
            • 12.7 Fresenius SE and Co. KGaA
              • Exhibit 127: Fresenius SE and Co. KGaA - Overview
              • Exhibit 128: Fresenius SE and Co. KGaA - Business segments
              • Exhibit 129: Fresenius SE and Co. KGaA - Key news
              • Exhibit 130: Fresenius SE and Co. KGaA - Key offerings
              • Exhibit 131: Fresenius SE and Co. KGaA - Segment focus
            • 12.8 Grifols SA
              • Exhibit 132: Grifols SA - Overview
              • Exhibit 133: Grifols SA - Business segments
              • Exhibit 134: Grifols SA - Key offerings
              • Exhibit 135: Grifols SA - Segment focus
            • 12.9 ICU Medical Inc.
              • Exhibit 136: ICU Medical Inc. - Overview
              • Exhibit 137: ICU Medical Inc. - Product / Service
              • Exhibit 138: ICU Medical Inc. - Key offerings
            • 12.10 JW Pharmaceutical Corp.
              • Exhibit 139: JW Pharmaceutical Corp. - Overview
              • Exhibit 140: JW Pharmaceutical Corp. - Product / Service
              • Exhibit 141: JW Pharmaceutical Corp. - Key offerings
            • 12.11 Otsuka Holdings Co. Ltd.
              • Exhibit 142: Otsuka Holdings Co. Ltd. - Overview
              • Exhibit 143: Otsuka Holdings Co. Ltd. - Business segments
              • Exhibit 144: Otsuka Holdings Co. Ltd. - Key offerings
              • Exhibit 145: Otsuka Holdings Co. Ltd. - Segment focus
            • 12.12 Pfizer Inc.
              • Exhibit 146: Pfizer Inc. - Overview
              • Exhibit 147: Pfizer Inc. - Product / Service
              • Exhibit 148: Pfizer Inc. - Key news
              • Exhibit 149: Pfizer Inc. - Key offerings
            • 12.13 Salius Pharma Pvt. Ltd.
              • Exhibit 150: Salius Pharma Pvt. Ltd. - Overview
              • Exhibit 151: Salius Pharma Pvt. Ltd. - Product / Service
              • Exhibit 152: Salius Pharma Pvt. Ltd. - Key offerings
            • 12.14 Sichuan Kelun Pharmaceutical Co. Ltd.
              • Exhibit 153: Sichuan Kelun Pharmaceutical Co. Ltd. - Overview
              • Exhibit 154: Sichuan Kelun Pharmaceutical Co. Ltd. - Product / Service
              • Exhibit 155: Sichuan Kelun Pharmaceutical Co. Ltd. - Key offerings
            • 12.15 Soxa Formulations and Research Pvt. Ltd.
              • Exhibit 156: Soxa Formulations and Research Pvt. Ltd. - Overview
              • Exhibit 157: Soxa Formulations and Research Pvt. Ltd. - Product / Service
              • Exhibit 158: Soxa Formulations and Research Pvt. Ltd. - Key offerings
            • 12.16 Terumo Group
              • Exhibit 159: Terumo Group - Overview
              • Exhibit 160: Terumo Group - Business segments
              • Exhibit 161: Terumo Group - Key news
              • Exhibit 162: Terumo Group - Key offerings
              • Exhibit 163: Terumo Group - Segment focus
            • 12.17 Vifor Pharma Management Ltd.
              • Exhibit 164: Vifor Pharma Management Ltd. - Overview
              • Exhibit 165: Vifor Pharma Management Ltd. - Product / Service
              • Exhibit 166: Vifor Pharma Management Ltd. - Key news
              • Exhibit 167: Vifor Pharma Management Ltd. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              intravenous iv solutions market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis